Abstract
Materials/Methods: Patients with RIMT were identified amongst Head-Neck cancer patients treated with definitive or adjuvant IMRT with prescribed radiotherapy (RT) dose . 56 Gy, in the period January 2005 to December 2008 and flagged as RIMT in prospective quality assurance systems. Clinical, dental and treatment related information was retrospectively obtained for each patient with RIMT. RIMT was graded (1-4) on clinical and management based criteria. Dose-volume parameters retrieved from treatment planning system were Dmax, D1cc, D2cc, D5cc, D10cc, Dmean and Dmin for dose to whole mandible, ipsilateral (side of RIMT) and contralateral hemi-mandible. Paired t-test was used for comparisons.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
